06/23/2026
Dr. Drew Weissman delivered the Paul I. Terasaki State-of-the-Art Lecture, sponsored by Terasaki Innovation Center, sharing how RNA medicine is expanding far beyond vaccines with potential applications in autoimmune disease, cancer, gene editing, in vivo CAR-T, and global health equity.
His message was clear: the future of medicine depends not only on scientific breakthroughs, but on making innovation accessible worldwide.